» Articles » PMID: 8790857

Nuclear Pore-targeting Complex and Its Role on Nuclear Protein Transport

Overview
Date 1996 May 1
PMID 8790857
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The process of selective nuclear protein transport is divided into at least two steps: 1) ATP-independent, nuclear localization signal (NLS)-dependent binding to the cytoplasmic face of nuclear pores and 2) ATP-dependent translocation through the nuclear pores. Using a digitonin-permeabilized cell-free transport assay, it was found that a karyophile forms a stable complex with a cytoplasmic fraction to target the nuclear pores. Since this complex shows nuclear pore-binding activity, we have referred to it as the nuclear Pore-Targeting Complex (PTAC). The complex contains two essential proteins. The 58 kDa component of PTAC (PTAC 58; importin alpha; karyopherin alpha) was found to bind directly to NLS. The 97 kDa component of PTAC (PTAC 97; importin beta; karyopherin beta) associates with PTAC 58, but not karyophile. A complex of PTAC 58 and PTAC 97 targets nuclear pores, depending on the presence of a karyophile. The data suggest that the initial step in nuclear protein transport occurs as a result of complex formation of a karyophile with PTAC 58 which is, in turn, bound to PTAC 97.

Citing Articles

KPNB1 Inhibitor Importazole Reduces Ionizing Radiation-Increased Cell Surface PD-L1 Expression by Modulating Expression and Nuclear Import of IRF1.

Yoshino H, Sato Y, Nakano M Curr Issues Mol Biol. 2021; 43(1):153-162.

PMID: 34069326 PMC: 8929148. DOI: 10.3390/cimb43010013.


Increased Nuclear Transporter KPNA2 Contributes to Tumor Immune Evasion by Enhancing PD-L1 Expression in PDAC.

Zhou K, Huang S, Hu L, Zhang X, Qin W, Zhang Y J Immunol Res. 2021; 2021:6694392.

PMID: 33728352 PMC: 7939744. DOI: 10.1155/2021/6694392.


Inhibition of Drp1 SUMOylation by ALR protects the liver from ischemia-reperfusion injury.

Huang J, Xie P, Dong Y, An W Cell Death Differ. 2020; 28(4):1174-1192.

PMID: 33110216 PMC: 8027887. DOI: 10.1038/s41418-020-00641-7.


Karyopherin-β1 Regulates Radioresistance and Radiation-Increased Programmed Death-Ligand 1 Expression in Human Head and Neck Squamous Cell Carcinoma Cell Lines.

Hazawa M, Yoshino H, Nakagawa Y, Shimizume R, Nitta K, Sato Y Cancers (Basel). 2020; 12(4).

PMID: 32276424 PMC: 7226044. DOI: 10.3390/cancers12040908.


Disease-specific alteration of karyopherin-α subtype establishes feed-forward oncogenic signaling in head and neck squamous cell carcinoma.

Hazawa M, Sakai K, Kobayashi A, Yoshino H, Iga Y, Iwashima Y Oncogene. 2019; 39(10):2212-2223.

PMID: 31822798 PMC: 7056645. DOI: 10.1038/s41388-019-1137-3.